Delta Plus variant

  • Scientists around the world and in India are concerned about ‘Delta plus’, an emerging form of the Delta variant of the novel coronavirus. 
  • This variant allows the virus to “escape” antibodies in recently approved treatment regimes. 

WHAT IS DELTA PLUS VARIANT?
  • Formally known as AY.1 or B.1.617.2.1, it’s a variant of Delta (B.1.617.2), which was first identified in India.
  • It has an additional mutation called K417N, which has previously been identified in the Beta variant (first found in South Africa) and the Gamma variant (first detected in Brazil).
  • The K417N, along with another mutation called K417T, is a mutation in the spike protein of the novel coronavirus.
  • These variants are characterized as being highly infectious and may reduce the potency of vaccines. 
WHY THE CONCERN?
  • The Delta variant is now regarded as the most prevalent one in India, comprising nearly 31% of the 21,000 community samples processed until late May. 
  • This variant has significant differences compared to the strain that has been used by pharma companies to design vaccines,
  • Tests are needed to check if the existing vaccines continue to be effective against the variants dominant now.
  • Vaccines, while effective, appear to produce fewer antibodies when confronted with variants such as Delta. 
  • The concern is that because the Delta variant has a cavalcade of mutations that have allowed it to dominate in several countries, including India, another form may pose new challenges to the management of the pandemic in India. 



Comments

Popular posts from this blog

Hamas V. PLO

G7 global corporate Tax Deal

The statue of Swami Vivekananda at the JNU campus